Volume 36 Issue 6
Nov.  2020
Turn off MathJax
Article Contents
GUO Xiao-yan, ZHANG Hai-lou, XIA Bao-mei, TAO Wei-wei, LI Wen-jia, XU Lian-tiao, SHEN Qin-qin, ZOU Zhi-lu, CHEN Gang. Haowang Formula Improved Cognitive Impairment in AD Mice Models and Related Mechanism[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(6): 831-836.
Citation: GUO Xiao-yan, ZHANG Hai-lou, XIA Bao-mei, TAO Wei-wei, LI Wen-jia, XU Lian-tiao, SHEN Qin-qin, ZOU Zhi-lu, CHEN Gang. Haowang Formula Improved Cognitive Impairment in AD Mice Models and Related Mechanism[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(6): 831-836.

Haowang Formula Improved Cognitive Impairment in AD Mice Models and Related Mechanism

  • Publish Date: 2020-11-10
  • OBJECTIVE To assess the effect of Haowang Formula (HWF) in treating Alzheimer's disease (AD) cognitive impairment using scopolamine mice model and senescence accelerated mice P8 (SAMP8) model, and investigated the underlying mechanism centered on PKA-mediated clearance of phosphorylated TAU and enhancement of synaptic plasticity. METHODS Mice were randomly divided into 4 groups in both models: Control group(CTL), Model group (Veh), Haowang Formula group and Donepezil group (Donepezil). Morris water maze (MWM) and novel object recognition test (NOR) were used to evaluate the cognitive ability of mice. Western Blot was used to detect the protein levels in PKA-GSK3β-TAU, PKA-CREB and its downstream molecule BDNF and synaptic proteins including SYNAPSIN1, GLUR1, and PSD95 in the hippocampus of SAMP8. RESULTS Under scopolamine model, compared to Model group, HWF and Donepezil distinctly improved times of crossing the platform in Morris water maze. Under SAMP8 model, both HWF and donepezil displayed therapeutic effect on escape latency and times of crossing the platform in MWM, and new object recognition index in NOR (P<0.01). However, HWF increased distance in target quadrant and showed better treatment effect on shortening escape latency than donepezil (P<0.01). In hippocampus of SAMP8 mice, HWF distinctly reduced the protein levels of TAU-ser404 by activating PKA-GSK3β-TAU pathway (P<0.01). It also reversed the down-regulation of PKA-CREB and its downstream molecule BDNF and synaptic proteins including SYNAPSIN1, GLUR1, and PSD95 (P<0.05,P<0.01). CONCLUSION HWF can improve cognitive impairment in AD mice models, which is related to PKA-mediated clearance of phosphorylated TAU and enhancement of synaptic plasticity.

     

  • loading
  • [1]
    史晓雪, 唐世琪. 阿尔茨海默病的治疗方法研究进展[J]. 职业与健康, 2018, 34(1): 134-137.
    [2]
    PINZ MP, DOS REIS AS, VOGT AG, et al. Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer's disease model[J]. Biomed Pharmacother, 2018, 105: 1006-1014.
    [3]
    WINSLOW BT, ONYSKO MK, STOB CM, et al. Treatment of Alzheimer disease[J]. Am Fam Physician, 2011,83(12):1403-1412.
    [4]
    GARCIA-OSTA A, CUADRADO-TEJEDOR M, GARCIA-BARROSO C, et al. Phosphodiesterases as therapeutic targets for Alzheimer's disease[J]. ACS Chem Neurosci, 2012, 3(11): 832-844.
    [5]
    EFTHYMIOUA G, GOATE AM. Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk[J]. Mol Neurodegeneration, 2017, 12: 43.
    [6]
    WU XL, PINA-CRESPO J, ZHANG YW, et al. Tau-mediated neurodegeneration and potential implications in diagnosis and treatment of Alzheimer's disease[J]. Chin Med J, 2017, 130(24): 2978-2990.
    [7]
    LIU Q, WANG SC, DING K. Research advances in the treatment of Alzheimer's disease with polysaccharides from traditional Chinese medicine[J]. Chin J Nat Med, 2017, 15(9): 641-652.
    [8]
    JESKY R, CHEN H. The neuritogenic and neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells[J]. BMC Complement Altern Med, 2016, 16: 26.
    [9]
    LYU J, JIA H, JIANG Y, et al. Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-β secretionin vitro[J]. Acta Physiol, 2009, 196(4): 419-425.
    [10]
    MAO JX, HUANG SC, LIU SF, et al. A herbal medicine for Alzheimer's disease and its active constituents promote neural progenitor proliferation[J]. Aging Cell, 2015, 14(5): 784-796.
    [11]
    王欣, 刘静. 孙思邈治“好忘”方特点浅析[J]. 山东中医药大学学报, 2000, 24(2): 93-94.
    [12]
    TRACY TE, GAN L. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy[J]. Bioessays, 2017, 39(4):1-9.
    [13]
    WU XL, PINA-CRESPO J, ZHANG YW, et al. Tau-mediated neurodegeneration and potential implications in diagnosis and treatment of Alzheimer's disease[J]. Chin Med J (Engl), 2017, 130(24): 2978-2990.
    [14]
    胡慧, 王平, 孔明望, 等. 阿尔茨海默病模型大鼠Tau蛋白异常磷酸化表达及补肾化痰法的干预作用[J]. 时珍国医国药, 2010, 21(10): 2681-2683.
    [15]
    CUBINKOVA V, VALACHOVA B, UHRINOVA I, et al. Alternative hypotheses related to Alzheimer's disease[J].Bratislava Med J, 2018, 119(4): 210-216.
    [16]
    KANDEL ER. The molecular biology of memory: CAMP, PKA, CRE, CREB-1, CREB-2, and CPEB[J]. Mol Brain, 2012, 5(1): 14.
    [17]
    ZHANG Y, MARH, LI XC, et al. Silencing I2PP2A rescues tau pathologies and memory deficits through rescuing PP2A and inhibiting GSK-3β signaling in human tau transgenic mice[J]. Front Aging Neurosci, 2014, 6: 123.
    [18]
    SUZUKI A, FUKUSHIMA H, MUKAWA T, et al. Upregulation of CREB-mediated transcription enhances both short- and long-term memory[J].J Neurosci, 2011, 31(24): 8786-8802.
    [19]
    CHEN Y, HUANG X, ZHANG YW, et al. Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloid[J]. J Neurosci, 2012, 32(33): 11390-11395.
    [20]
    SANDHYA VK, RAJU R, VERMA R, et al. A network map of BDNF/TRKB and BDNF/p75NTR signaling system[J]. J Cell Commun Signal, 2013, 7(4): 301-307.
    [21]
    VOINESKOS AN, LERCH JP, FELSKY D, et al. The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease[J]. Arch Gen Psychiatry, 2011, 68(2): 198-206.
    [22]
    GUO HB, CHENG YF, WANG CM, et al. FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects[J]. Neuropharmacology, 2017, 116: 260-269.
    [23]
    彭英, 李萍萍, 李琳, 等. 抗阿尔茨海默病药物临床研究进展[J]. 药学学报, 2016, 51(8): 1185-1195.
    [24]
    汪惠琳, 徐清清, 郑国庆. 精神疾病治疗进展(四): 阿尔茨海默病[J]. 医药导报, 2017, 36(10): 1148-1152.
    [25]
    KLINKENBERG I, BLOKLAND A. The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies[J]. Neurosci Biobehav Rev, 2010, 34(8): 1307-1350.
    [26]
    SCHLIEBS R, ARENDT T. The cholinergic system in aging and neuronal degeneration[J].Behav Brain Res, 2011, 221(2): 555-563.
    [27]
    CHENG XR, ZHOU WX, ZHANG YX. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model[J]. Ageing Res Rev, 2014, 13: 13-37.
    [28]
    PALLAS M, CAMINS A, SMITH MA, et al. From aging to Alzheimer's disease: Unveiling “the switch” with the senescence-accelerated mouse model (SAMP8)[J]. J Alzheimer's Dis, 2008, 15(4): 615-624.
    [29]
    TUCKER LB, VELOSKY AG, MCCABE JT. Applications of the Morris water maze in translational traumatic brain injury research[J]. Neurosci Biobehav Rev, 2018, 88: 187-200.
    [30]
    PAN WS, HAN S, KANG L, et al. Effects of dihydrotestosterone on synaptic plasticity of theHippocampus in mild cognitive impairment male SAMP8 mice[J]. Exp Ther Med, 2016, 12(3): 1455-1463.
    [31]
    ZHANG ZX, ZHAO RP, WANG DS, et al. Fuzhisan ameliorates the memory deficits in aged SAMP8 mice via decreasing aβ production and tau hyperphosphorylation of theHippocampus[J]. Neurochem Res, 2016, 41(11): 3074-3082.
    [32]
    ZHANG SJ, LUO D, LI L, et al. Ethyl acetate extract components of bushen-Yizhi formula provides neuroprotection against scopolamine-induced cognitive impairment[J]. Sci Rep, 2017, 7(1): 9824.
    [33]
    SHI YH, HUANG WY, WANG Y, et al. Bis(9)-(-)-Meptazinol, a novel dual-binding AChE inhibitor, rescues cognitive deficits and pathological changes in APP/PS1 transgenic mice[J]. Transl Neurodegener, 2018, 7: 21.
    [34]
    ZHOU W, ZHONG G, FU S, et al. Microglia-based phenotypic screening identifies a novel inhibitor of neuroinflammation effective in Alzheimer's disease models[J]. ACS Chem Neurosci, 2016, 7(11): 1499-1507.
    [35]
    EVANS DB, RANK KB, BHATTACHARYA K, et al. Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase Ⅱ inhibits tau's ability to promote microtubule assembly[J]. J Biol Chem, 2000, 275(32): 24977-24983.
    [36]
    IQBAL K, GRUNDKE-IQBAL I. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease[J]. Mol Neurobiol, 1991, 5(2/3/4): 399-410.
    [37]
    BOLAND B, YUWH, CORTI O, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing[J]. Nat Rev Drug Discov, 2018, 17(9): 660-688.
    [38]
    AVILA J. Tau phosphorylation and aggregation in Alzheimer's disease pathology[J]. FEBS Lett, 2006, 580(12): 2922-2927.
    [39]
    BRAIDY N, ESSA MM, POLJAK A, et al. Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease[J]. Oncotarget, 2016, 7(40): 64589-64604.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (473) PDF downloads(638) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return